InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,497.47
(
0.19%
)
US TECH 100
19,448.40
(
0.21%
)
Dow Jones
38,967.07
(
0.34%
)
Brent Oil
85.21
(
0.60%
)
Bitcoin
64,819.78
(
-0.17%
)
Post# of 199
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Rkmatters

Send PM Follow Ignore
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Rkmatters

Re: None

Saturday, 05/30/2015 1:20:57 PM

Saturday, May 30, 2015 1:20:57 PM

Post# of 199
Under the radar Bellicum has turned a Car-t into a solid tumor killer contender. Today's clinical abstract is fantastic.

http://ir.bellicum.com/phoenix.zhtml?c=253830&p=irol-newsArticle&ID=2054576

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUxOTUxOTB8Q2hpbGRJRD01ODI3NDU=

Their pipeline is robust, with blood (t cell depleted), dendritic cells and Car-T on/off switch technologies.

http://ir.bellicum.com/phoenix.zhtml?c=253830&ut=1433006193&p=RssLanding&cat=news&id=2048147

I'm expecting the market to take notice soon. :)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up